trans-4-methylcyclohexylamine has been researched along with Chagas Disease in 1 studies
*Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, K; Namatame, I; Niimi, T; Sakashita, H; Tanabe, E; Tani, O; Tateishi, Y; Yamasaki, K | 1 |
1 other study(ies) available for trans-4-methylcyclohexylamine and Chagas Disease
| Article | Year |
|---|---|
An NMR Biochemical Assay for Fragment-Based Drug Discovery: Evaluation of an Inhibitor Activity on Spermidine Synthase of Trypanosoma cruzi.
Topics: Chagas Disease; Cyclohexylamines; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Activation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Spermidine Synthase; Structure-Activity Relationship; Time Factors; Trypanosoma cruzi | 2016 |